148 related articles for article (PubMed ID: 33910154)
1. Pretreatment qEEG biomarkers for predicting pharmacological treatment outcome in major depressive disorder: Independent validation from the NeuroPharm study.
Ip CT; Olbrich S; Ganz M; Ozenne B; Köhler-Forsberg K; Dam VH; Beniczky S; Jørgensen MB; Frokjaer VG; Søgaard B; Christensen SR; Knudsen GM
Eur Neuropsychopharmacol; 2021 Aug; 49():101-112. PubMed ID: 33910154
[TBL] [Abstract][Full Text] [Related]
2. EEG alpha asymmetry as a gender-specific predictor of outcome to acute treatment with different antidepressant medications in the randomized iSPOT-D study.
Arns M; Bruder G; Hegerl U; Spooner C; Palmer DM; Etkin A; Fallahpour K; Gatt JM; Hirshberg L; Gordon E
Clin Neurophysiol; 2016 Jan; 127(1):509-519. PubMed ID: 26189209
[TBL] [Abstract][Full Text] [Related]
3. NeuroPharm study: EEG wakefulness regulation as a biomarker in MDD.
Ip CT; Ganz M; Dam VH; Ozenne B; Rüesch A; Köhler-Forsberg K; Jørgensen MB; Frokjaer VG; Søgaard B; Christensen SR; Knudsen GM; Olbrich S
J Psychiatr Res; 2021 Sep; 141():57-65. PubMed ID: 34175743
[TBL] [Abstract][Full Text] [Related]
4. Stability of frontal alpha asymmetry in depressed patients during antidepressant treatment.
van der Vinne N; Vollebregt MA; van Putten MJAM; Arns M
Neuroimage Clin; 2019; 24():102056. PubMed ID: 31795035
[TBL] [Abstract][Full Text] [Related]
5. Pretreatment Rostral Anterior Cingulate Cortex Theta Activity in Relation to Symptom Improvement in Depression: A Randomized Clinical Trial.
Pizzagalli DA; Webb CA; Dillon DG; Tenke CE; Kayser J; Goer F; Fava M; McGrath P; Weissman M; Parsey R; Adams P; Trombello J; Cooper C; Deldin P; Oquendo MA; McInnis MG; Carmody T; Bruder G; Trivedi MH
JAMA Psychiatry; 2018 Jun; 75(6):547-554. PubMed ID: 29641834
[TBL] [Abstract][Full Text] [Related]
6. Predicting Treatment Outcome in Major Depressive Disorder Using Serotonin 4 Receptor PET Brain Imaging, Functional MRI, Cognitive-, EEG-Based, and Peripheral Biomarkers: A NeuroPharm Open Label Clinical Trial Protocol.
Köhler-Forsberg K; Jorgensen A; Dam VH; Stenbæk DS; Fisher PM; Ip CT; Ganz M; Poulsen HE; Giraldi A; Ozenne B; Jørgensen MB; Knudsen GM; Frokjaer VG
Front Psychiatry; 2020; 11():641. PubMed ID: 32792991
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of a Machine Learning Model Based on Pretreatment Symptoms and Electroencephalographic Features to Predict Outcomes of Antidepressant Treatment in Adults With Depression: A Prespecified Secondary Analysis of a Randomized Clinical Trial.
Rajpurkar P; Yang J; Dass N; Vale V; Keller AS; Irvin J; Taylor Z; Basu S; Ng A; Williams LM
JAMA Netw Open; 2020 Jun; 3(6):e206653. PubMed ID: 32568399
[TBL] [Abstract][Full Text] [Related]
8. Frontal and rostral anterior cingulate (rACC) theta EEG in depression: implications for treatment outcome?
Arns M; Etkin A; Hegerl U; Williams LM; DeBattista C; Palmer DM; Fitzgerald PB; Harris A; deBeuss R; Gordon E
Eur Neuropsychopharmacol; 2015 Aug; 25(8):1190-200. PubMed ID: 25936227
[TBL] [Abstract][Full Text] [Related]
9. Resting-State Quantitative Electroencephalography Demonstrates Differential Connectivity in Adolescents with Major Depressive Disorder.
McVoy M; Aebi ME; Loparo K; Lytle S; Morris A; Woods N; Deyling E; Tatsuoka C; Kaffashi F; Lhatoo S; Sajatovic M
J Child Adolesc Psychopharmacol; 2019 Jun; 29(5):370-377. PubMed ID: 31038351
[No Abstract] [Full Text] [Related]
10. EEG biomarker informed prescription of antidepressants in MDD: a feasibility trial.
van der Vinne N; Vollebregt MA; Rush AJ; Eebes M; van Putten MJAM; Arns M
Eur Neuropsychopharmacol; 2021 Mar; 44():14-22. PubMed ID: 33509659
[TBL] [Abstract][Full Text] [Related]
11. Predicting treatment response using EEG in major depressive disorder: A machine-learning meta-analysis.
Watts D; Pulice RF; Reilly J; Brunoni AR; Kapczinski F; Passos IC
Transl Psychiatry; 2022 Aug; 12(1):332. PubMed ID: 35961967
[TBL] [Abstract][Full Text] [Related]
12. Pretreatment Rostral Anterior Cingulate Cortex Connectivity With Salience Network Predicts Depression Recovery: Findings From the EMBARC Randomized Clinical Trial.
Whitton AE; Webb CA; Dillon DG; Kayser J; Rutherford A; Goer F; Fava M; McGrath P; Weissman M; Parsey R; Adams P; Trombello JM; Cooper C; Deldin P; Oquendo MA; McInnis MG; Carmody T; Bruder G; Trivedi MH; Pizzagalli DA
Biol Psychiatry; 2019 May; 85(10):872-880. PubMed ID: 30718038
[TBL] [Abstract][Full Text] [Related]
13. Generalizability of treatment outcome prediction in major depressive disorder using structural MRI: A NeuroPharm study.
Beliveau V; Hedeboe E; Fisher PM; Dam VH; Jørgensen MB; Frokjaer VG; Knudsen GM; Ganz M
Neuroimage Clin; 2022; 36():103224. PubMed ID: 36252556
[TBL] [Abstract][Full Text] [Related]
14. Response to Pharmacological Treatment in Major Depression Predicted by Electroencephalographic Alpha Power - a Pilot Naturalistic Study.
Kandilarova SS; Terziyski KV; Draganova AI; Stoyanov DS; Akabaliev VH; Kostianev SS
Folia Med (Plovdiv); 2017 Sep; 59(3):318-325. PubMed ID: 28976896
[TBL] [Abstract][Full Text] [Related]
15. Utility of event-related potentials in predicting antidepressant treatment response: An iSPOT-D report.
van Dinteren R; Arns M; Kenemans L; Jongsma ML; Kessels RP; Fitzgerald P; Fallahpour K; Debattista C; Gordon E; Williams LM
Eur Neuropsychopharmacol; 2015 Nov; 25(11):1981-90. PubMed ID: 26282359
[TBL] [Abstract][Full Text] [Related]
16. The comparative effectiveness of electroencephalographic indices in predicting response to escitalopram therapy in depression: A pilot study.
Baskaran A; Farzan F; Milev R; Brenner CA; Alturi S; Pat McAndrews M; Blier P; Evans K; Foster JA; Frey BN; Giacobbe P; Lam RW; Leri F; MacQueen GM; Müller DJ; Parikh SV; Rotzinger S; Soares CN; Strother SC; Turecki G; Kennedy SH;
J Affect Disord; 2018 Feb; 227():542-549. PubMed ID: 29169123
[TBL] [Abstract][Full Text] [Related]
17. The Antidepressant Treatment Response Index as a Predictor of Reboxetine Treatment Outcome in Major Depressive Disorder.
Caudill MM; Hunter AM; Cook IA; Leuchter AF
Clin EEG Neurosci; 2015 Oct; 46(4):277-84. PubMed ID: 25258429
[TBL] [Abstract][Full Text] [Related]
18. Change in Quantitative EEG Theta Cordance as a Potential Predictor of Repetitive Transcranial Magnetic Stimulation Clinical Outcome in Major Depressive Disorder.
Hunter AM; Nghiem TX; Cook IA; Krantz DE; Minzenberg MJ; Leuchter AF
Clin EEG Neurosci; 2018 Sep; 49(5):306-315. PubMed ID: 29224411
[TBL] [Abstract][Full Text] [Related]
19. The promise of the quantitative electroencephalogram as a predictor of antidepressant treatment outcomes in major depressive disorder.
Hunter AM; Cook IA; Leuchter AF
Psychiatr Clin North Am; 2007 Mar; 30(1):105-24. PubMed ID: 17362807
[TBL] [Abstract][Full Text] [Related]
20. Midline and right frontal brain function as a physiologic biomarker of remission in major depression.
Cook IA; Hunter AM; Abrams M; Siegman B; Leuchter AF
Psychiatry Res; 2009 Nov; 174(2):152-7. PubMed ID: 19853417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
